Skip to content

Study on the dynamics of perioperative hemoglobin concentration in patients undergoing autologous blood transfusion for orthopedic surgery

Study on the dynamics of perioperative hemoglobin concentration in patients undergoing autologous blood transfusion for orthopedic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400083121
Enrollment
Unknown
Registered
2024-04-16
Start date
2024-04-16
Completion date
Unknown
Last updated
2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Observation of dynamic changes in perioperative haemoglobin concentration in patients undergoing autologous blood transfusion for orthopaedic spinal surgery

Interventions

No blood products group (Postoperatively, the patients drainage fluid was retained once a day and sent to the laboratory for routine blood tests and recording of data until the orthopaedic surgeon's j
Intraoperative autologous blood transfusion only group (Postoperatively, the patients drainage fluid was retained once a day and sent to the laboratory for routine blood tests and recording of data un
Autologous blood transfusion + allogeneic blood group (Postoperatively, the patients drainage fluid was retained once a day and sent to the laboratory for routine blood tests and recording of data unt

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) age =18 years; (2) American Society of Anesthesiologists (ASA) class I to III; (3) patients undergoing elective orthopaedic spine surgery.

Exclusion criteria

Exclusion criteria: (1) severe obstruction of coronary, peripheral and/or carotid arteries; (2) preoperative low haemoglobin (<8 g/dL); (3) haematological disorders; (4) renal or hepatic dysfunction; (5) preoperative prophylactic anticoagulation therapy; (6) surgery for uncomplicated malignancy or concomitant malignancy.

Design outcomes

Primary

MeasureTime frame
HGB;

Secondary

MeasureTime frame
Red blood cell count;Haemoglobin concentration of the patient's drainage fluid;

Countries

China

Contacts

Public ContactYinyin Qu

Peking University Third Hospital

quyinyin@bjmu.edu.cn+86 134 6675 9889

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026